RNU6-866P

Across TCGA pan-cancer cohorts, RNU6-866P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RNU6-866P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-866P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-866P expression acts as an unfavorable survival marker, although some lineages such as BRCA and STAD show a favorable association.

KIRC, BRCA, and LIHC are the cancer types where RNU6-866P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.735	0.839	.003	98	view →
BRCA	OS	Tertile	III,IV	0.780	0.446	.002	79	view →
LIHC	DFS	Tertile	All	0.370	0.567	<.001	57	view →
KICH	DFS	Tertile	All	0.401	0.913	<.001	54	view →
DLBC	DFS	Tertile	All	0.333	0.959	<.001	51	view →
COAD	OS	Tertile	III,IV	0.227	0.620	.005	27	view →
MESO	OS	Tertile	II,III,IV	0.289	0.584	.010	18	view →
THCA	DFS	Tertile	II,III,IV	0.414	0.719	.012	18	view →
LUSC	DFS	Tertile	III,IV	0.159	0.811	.001	18	view →
ACC	OS	Tertile	III,IV	0.251	0.640	.010	18	view →
STAD	OS	Median	IV	0.723	0.339	.028	12	view →
LUAD	OS	Tertile	All	0.858	0.786	.030	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RNU6-866P–KIRC (OS)

Open the KIRC breakdown →